Lifecore Biomedical, Inc. De (LFCR) Price to Earnings (2010 - 2025)

Lifecore Biomedical has reported Price to Earnings for 16 years, with the latest figure at 14.06 in Q2 2025.

• On a quarterly basis, Price to Earnings rose 42.03% year-over-year to 14.06 in Q2 2025; TTM through May 2025 was 4.27, a 129.86% decrease from a year earlier, with the FY2025 full-year figure at 5.61, down 139.23% from the prior year.
• Price to Earnings was 14.06 for Q2 2025 at Lifecore Biomedical, down from 13.27 in the prior quarter.
• The five-year high for Price to Earnings was 16.09 in Q4 2023, with the low at 46.85 in Q1 2021.
• Average Price to Earnings over 5 years is 15.36, with a median of 16.76 recorded in 2025.
• The largest YoY upside for Price to Earnings was 424.59% in 2024 against a maximum downside of 295.69% in 2024.
• Over 5 years, Price to Earnings stood at 6.64 in 2021, then slumped by 198.05% to 19.8 in 2022, then soared by 181.25% to 16.09 in 2023, then tumbled by 293.07% to 31.06 in 2024, then jumped by 54.75% to 14.06 in 2025.
• The last three Price to Earnings figures came in at 14.06 (Q2 2025), 13.27 (Q1 2025), and 31.06 (Q4 2024), per Business Quant data.